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Formation of a eutherian mammal requires concurrent establishment of
embryonic and extraembryonic lineages. The functions of the trophectoderm
and primitive endoderm are to enable implantation in the maternal uterus,
axis specification and delivery of nutrients. The pluripotent epiblast represents
the founding cell population of the embryo proper, which is protected from
ectopic and premature differentiation until it is required to respond to induc-
tive cues to form the fetus. While positional information plays a major role in
specifying the trophoblast lineage, segregation of primitive endoderm from
epiblast depends upon gradual acquisition of transcriptional identity, directed
but not initiated by fibroblast growth factor (FGF) signalling. Following early
cleavage divisions and formation of the blastocyst, cells of the inner cell mass
lose totipotency. Developing epiblast cells transiently attain the state of naive
pluripotency and competence to self-renew in vitro as embryonic stem cells
and in vivo by means of diapause. This property is lost after implantation as
the epiblast epithelializes and becomes primed in preparation for gastrulation
and subsequent organogenesis.1. Background
Mammalian preimplantation development combines establishment of a small
populationof founder cells for the fetuswith early differentiationof extraembryonic
tissues required to facilitate implantation, patterning and nutrition. The transcrip-
tional and translational machinery becomes activated to institute self-sufficient
cell populations from the maternally dominated zygote. Once established, the
embryonic lineage must be protected from premature differentiation to remain
susceptible to subsequent positional and temporal patterning in order to orches-
trate formation of all the tissues in the body. This property is known as naive
pluripotency [1]. An interesting and biomedically relevant asset of the murine pre-
implantation epiblast is its ability to remain undifferentiated and proliferate when
explanted into appropriate culture conditions in the form of embryonic stem (ES)
cells. In this chapter, we review the current knowledge of how this intriguing
state of ‘naive’ pluripotency is acquired in vivo.2. Totipotency is a unique property of cleavage stages
The fertilized egg is capable of producing all embryonic as well as extraembryo-
nic lineages. This distinctive ability is referred to as totipotency. However,
preparation for totipotency in mammals begins long before fertilization. In
mouse, the volume of the developing oocyte increases approximately 500-
fold during intra-ovarian growth. Continuous transcription of the maternal
genome yields around 100 pg messenger RNA in mature oocytes, with some
transcripts remaining dormant in order to become activated after fertilization.
By contrast, sperm has lost most of its organelles during spermatogenesis in
exchange for motility and therefore depends on the egg to boot the embryonic
genome. After fertilization, maternal proteins and transcripts pave the way to
the first major wave of transcription at the 2-cell stage in mouse [2] and continue
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Figure 1. Overview of embryonic potential in relation to developmental stage from zygote to egg cylinder. Cleavage is indicated by the dotted line and correlates
with totipotency (blue). Naive pluripotency (yellow) is established at the mid-blastocyst stage and persists until implantation. The terms totipotency, naive
pluripotency and primed pluripotency (red) apply to the embryonic lineage only. (Online version in colour.)
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2to play a role in the initial stages of development. The first five
cell cycles, commonly referred as cleavage divisions, are charac-
terized by a predominant S-phase, while G-phases are present
but short and variable [3,4]. Cleavage occurs in the absence of
cellular growth or increase in total cell mass [5] and strictly
depends on the large cytosolic compartment of the fertilized
egg (figure 1). Cells generated by cleavage divisions are referred
to as blastomeres. At the 2-cell stage, blastomeres retain the abil-
ity to form an entire conceptus, evident from the formation of
identical twins and demonstrated by the production of viable
offspring inmice after destruction of one of the two blastomeres
[6,7]. However, monozygotic twins are a rare phenomenon and
recent work revealed that a minimum of four preimplantation
epiblast cells has to be established for successful normal devel-
opment [8].Moreover, the efficiency formonozygotic twins can
be increased by modulation of fibroblast growth factor (FGF)
and Wnt signalling [8].
Individual blastomeres of the 4- and 8-cell stage can also
progress in development and form trophoblastic vesicles as
well as small blastocysts [9], which can implant in the
uterus when transferred into a synchronized recipient [10].
However, the resultant decidua mostly contained trophoblast
giant cells and on only one occasion a retarded embryo [10],
suggesting that single 1/4 and 1/8 blastomeres are not
capable of producing an entire fetus on their own. Exper-
iments in which isolated blastomeres from 4- and 8-cell
stages were aggregated with host blastomeres from another
embryo have shown that they are able to differentiate into
both trophectoderm and inner cell mass (ICM) and yield
viable pups [11]. Thus, their failure to form a normal fetus
in isolation is most probably due to inadequate numbers of
cells, rather than a restriction in developmental potential.
The fact that all blastomeres derived from the 4- and 8-cell
stage contribute to both extraembryonic and embryonic
lineages demonstrates their principal equipotency.3. Compaction controls the first lineage decision
One of the most intriguing questions in developmental
biology is how lineage identity can be acquired from appar-
ently uniform 8-cell blastomeres. A possible answer could
be that early blastomeres might not be as identical as they
appear. Several studies have highlighted differences between
individual blastomeres, including differential methylation
patterns [12], potency under the influence of certain con-
ditions [13] and transcription factor kinetics [14]. However,
the majority of blastomeres retain embryonic and extraem-
bryonic potential and differentiate based on their position
within the 8- to 16-cell embryo [15].How do blastomeres ‘sense’ their position? A crucial event
preceding the first lineage decision is compaction, which
occurs at the late 8-cell stage, at around embryonic day (E)
2.75. During compaction, the blastomeres increase their inter-
cellular interactions, thereby providing the essential spatial
queues for the first lineage decision in the mammalian
embryo. This allows the establishment of differential compart-
ments. Initially formulated as the ‘inside–outside’ hypothesis
[9], subsequent experiments have confirmed that the spatial
location of individual blastomeres is instructive for their sub-
sequent lineage allocation [11]. In normal development,
the outer cells of the morula become biased towards the first
extraembryonic lineage, the trophectoderm. Trophectoderm
is required for implantation and subsequently will give rise
to the placenta, an extraembryonic organ pivotal for nourish-
ment, detoxification and patterning of the developing fetus
[16]. By contrast, cells located in the inside tend to form the
ICM of the early blastocyst. ICM cells maintain expression of
the POU-domain transcription factor Oct4 (Pou5f1), which is
downregulated in outside cells. In the absence of Oct4, the
inside cells fail to maintain their identity and differentiate
into trophectoderm [17]. Using ES cells, it has been shown
that Oct4 acts cooperatively with Sox2 to induce expression
of several pluripotency genes, including FGF4 [18] and
Nanog [19]. In line with this, embryo profiling at single-cell
resolution revealed Sox2 and Id2 as the earliest markers of
inner and outer cells, respectively, specifically upregulated at
the 16- and 32-cell stage [20].
During compaction, intercellular adhesion depends on
E-cadherin [21], and outside cells acquire apical–basal polarity
by asymmetric localization of the polarity proteins atypical
protein kinase C [22], Par3 [23] and the actin-associated protein
ezrin [24]. Interferencewith polarity regulators byRNAimicro-
injection perturbs trophectoderm development [23,25], placing
polarization upstream of the first lineage decision in the
embryo, but downstream of the ‘inside–outside’ spatial
location of the individual blastomeres. This polarity is given
particular consideration in the ‘polarity’ model of the first lin-
eage decision during cleavage [26]. Key to the model is that
the embryo becomes radially polarized at the compacted
morula stage, originally discovered by the formation of an
external microvillous pole on each blastomere. The model
then suggests that this polarity can be inherited during the
next (fourth) cleavage division, as most blastomeres will give
rise to one polar cell, which inherits the outside surface, and
one apolar cell, completely engulfed by other blastomeres.
The remaining cells divide symmetrically by splitting the
microvillous apical domain, thereby producing two polarized
daughters, both of which harbour an outside surface. This
model is consistent with the morphology of an average 16-cell
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Figure 2. Hippo signalling and an ‘inside’ requirement for the establishment of the embryonic lineage. (a) Schematic of Hippo signalling activities in inside and
outside cells of a 16-cell morula. (b) Hippo signalling alone is not sufficient for embryonic lineage formation. Potential signalling activities mediated by the inside
environment are outlined. (Online version in colour.)
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3embryo, which contains approximately 10–14 outer, polar and
2–6 inner, apolar cells [26–28]. It is worth pointing out that cell
fates are not determined in the initial stages of blastocyst for-
mation, as outside 16-cell blastomeres still retain the potential
to become ICM at robust frequencies when put into an earlier
stage. Moreover, aggregations of purely outer cells can form a
newembryo, capable of development in theuterus [15], provid-
ing further evidence for the persistence of totipotency in a
substantial proportion of blastomeres at this stage.4. Hippo signalling conveys cellular polarity into
lineage-specific gene expression
Akey question in the context of embryonic lineage specification
is how ‘inside’ or ‘outside’ spatial information is translated
into transcriptional programmes. These are established by
lineage-specific master regulators, including Cdx2 and Gata3
for trophectoderm versus Oct4, Sox2 and Nanog in the ICM
[20,29–32]. Cdx2 null embryos are capable of trophectoderm
specification but require Cdx2 for morphological integrity,
subsequent development and implantation [33]. The discovery
that loss of Tead4 leads to complete failure in blastocyst cavity
formation places it upstream of the trophectoderm tran-
scriptional network [34,35]. Intriguingly, Tead4 activity is not
mediated by specific expression, but rather by intracellular
localization regulated by the Hippo signalling cascade [36].
Hippo signalling is a highly evolutionarily conserved pathway,
which, in the context of themouse embryo, integrates positional
information into lineage specification (figure 2a). In mamma-
lian embryos, Hippo signalling is active in inside cells when
Lats1/2 phosphorylates the Yorki homologues Yap1 and
Wwtr1 [36]. Phosphorylated Yap1 is excluded from the nucleus
and degraded. Consequently, Yap1 cannot act as co-activator
for Tead4, resulting in failure to induce the trophectodermal
programmevia expression ofGata3 andCdx2 [36,37]. Inoutside
cells, Lats1/2 remains inactive, allowing Yap1 to enter the
nucleus, and in combination with Tead4, to prime the cell
towards trophectoderm. Consistent with this, reduction of
Lats1/2 in the early preimplantation embryo prevents ICM lin-
eage formation [38]. Recent work suggests that Lats1/2 activity
is controlled by Nf2, which promotes interaction between the
adherens junctions and Amot, another regulatory component
of Hippo signalling in early mouse development [39,40].5. Inner cell mass specification requires an
‘inside’ environment
Hippo signalling alone is not sufficient to control entirely the
first lineage decision. Nf2 overexpression fails to alter Yap
localization, probably because of other missing components
in outside cells [40]. Knockdown of Lats1/2 leads to ectopic
Cdx2 expression in the ICM, but concurrent with persistent
expression of Oct4 and Nanog, suggesting incomplete con-
version of inner cells to bona fide trophectoderm [38]. Thus,
additional information may be required to establish ICM
fate [38], besides the lack of an apical domain. For instance,
inside cells may use gap junction-mediated intercellular com-
munication and adherens junctions, potentially leading to
cytoskeletal alterations and signalling activities via focal
adhesion kinases (figure 2b). Furthermore, inside cells may
reside in a privileged position to receive signalling molecules.
Considering the confined intercellular space, even small
amounts of secreted ligand would be experienced at higher
concentrations inside. Finally, inside cells may be exposed
to a specific ‘basal’ environment as the result of asymmetrical
protein localization in outside cells. Functional evidence for an
‘inside’ requirement in addition to Hippo signalling comes
fromblastomeres grown in isolation [41]. Blastomereswere sep-
aratedafter eachof the first five cell divisions (1/32), subjected to
lineage marker expression profiling, and compared to ICM and
trophectoderm cells. Although their expression patternwas dis-
tinct from both, it was closer to trophectoderm than ICM [41],
corroborating the requirement for an inside environment for
ICM specification. This study also demonstrated that singled
blastomeres preferentially contribute to trophectoderm in
morula aggregations [41]. Interestingly, Hippo signalling is
induced in singled blastomeres, suggesting that loss of apical–
basal polarity is insufficient to adopt ICM fate (figure 3). In sup-
port of this, blastomereshave the ability togive rise to functional
trophectoderm when transferred into a recipient female as
single cells, but do not form embryonic tissues [10]. Embryos
at the 4-cell stage denuded of the zona pellucida can rearrange
their cells into various configurations during culture. Those
adopting a linear configuration, where intercellular interactions
are low, result in blastocysts with significantly fewer ICM cells
[42] and exhibit inferior development when transferred into
the uterus, compared with tetrahedral configurations, where
intercellular interactions are maximized [43]. Single 1/4 and
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Figure 3. Summary of the cellular characteristics of blastomeres in the
embryo and singled blastomeres grown in isolation [41]. Although singled
blastomeres lack apical–basal polarity and active Hippo signalling (similar
to ‘inside’ cells destined to become ICM), they partially recapitulate trophec-
toderm identity. This suggests an important role for the ‘inside’ environment
in the establishment of the embryonic lineage, which is lacking in singled
blastomeres. (Online version in colour.)
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41/8 blastomeres give rise to ‘blastocysts’ at frequencies of 40%
and 15%, respectively, while the numberof empty trophoblastic
vesicles increases [9]. Collectively, these data suggest that blas-
tomeres grown in isolation, despite the loss of apical–basal
polarity, become biased towards trophectoderm and fail to
enter the embryonic lineage.6. Totipotency is gradually lost in the inner
cell mass
A widely understated characteristic of the early ICM is its
totipotency (figure 1). In this context, we define totipotency
as the ability of a cell to contribute to all embryonic and extra-
embryonic lineages. Clearly, this totipotency is different from
the ‘absolute’ totipotency of the zygote, which is capable of
forming an entire organism from one cell. However, ICMs
isolated from early blastocysts have the ability to regenerate
trophectoderm, resulting in miniature blastocysts [44,45],
and can differentiate into trophectoderm when explanted
in vitro [46,47]. Furthermore, they can contribute to trophecto-
derm in ICM–morula aggregations [48]. Aggregation of
several isolated ICMs can compensate for cell numbers and
regulate their combined size to produce apparently normal
blastocysts. Strikingly, more than one-third of these aggre-
gates give rise to complete egg cylinders upon transfer into
recipient female mice [48]. A recent study tested the develop-
mental potential of ICM cells at various blastocyst stages and
found that early ICM cells frequently contribute to trophecto-
derm when injected into a morula, confirming the previously
observed developmental plasticity [49]. This ability is gradu-
ally lost after E3.5 when the ICM cell number exceeds
approximately 16–19 cells [48,49], concomitant with the
second lineage decision in the mouse embryo: the segregation
of pluripotent epiblast and primitive endoderm (PrE).7. The second lineage decision: partitioning the
inner cell mass into preimplantation epiblast
and primitive endoderm
With the advent of accessible custom-made antibodies and
fluorescent lineage reporters, the process of PrE and epiblastsegregation has been interrogated and is reviewed in great
detail elsewhere [50–54]. Here, we outline the differences of
the second lineage decision compared to theposition-dependent
induction of trophectoderm discussed above.
The early PrE marker, Gata6, is initially co-expressed with
the pluripotent epiblast marker, Nanog, in the early ICM [55].
Consistent with this, a recent study has shown that at the early
blastocyst stage (32-cell), the transcriptome of individual
ICM cells is indistinguishable [56]. However, within the next
couple of hours of development, small transcriptional changes
become progressively manifested and the cells subsequently
segregate into two discrete populations [20,56]. In mouse,
this process is mainly driven by FGF signalling [57,58]. A
cardinal feature of epiblast cells is their temporal unresponsive-
ness to FGF signalling during the segregation process.
Transcriptome analysis of early ICM and epiblast cells has
shown that FGFR2, FGFR3 and FGFR4 are specific to the PrE
lineage, while FGFR1 is expressed in all cells [56]. Loss of
FGF4, FGFR2 or its downstream mediator, Grb2, ablates PrE
formation [57,59,60], whereas loss of the other FGF receptors
exhibits phenotypes at later stages of development. Therefore,
FGFR2 is the essential receptor for PrE specification. However,
initiation of the PrE transcriptional programme does not exclu-
sively depend on FGF signalling; embryos completely devoid
of FGF4 exhibit mosaic expression of early markers of PrE,
such as Gata6 and Sox17 [61].
In line with the genetic evidence, exogenous modulation of
FGF signalling in culture from the mid-blastocyst stage or ear-
lier influences ICM cell fate [62–64]. Inhibition of the FGF/
Erk pathway with synthetic inhibitors directs ICM cells to
become epiblast, whereas supplementation with exogenous
FGF4 or FGF2 leads preferentially to PrE. The high concen-
trations of ligand required to accomplish this lineage switch
seem somewhat perplexing, but these may approximate in
real terms to the high expression levels of FGF4 secreted by epi-
blast progenitors [56,65] acting over a comparatively short
range within the ICM. Evidence that physiological levels of
FGF4 can direct immature ICM cells to become PrE is provided
by formation of chimaeras between ES cells and cleavage stage
embryos. During the aggregation process, ES cellswill preferen-
tially occupy the inside compartment of the embryo, displacing
the host cells. The resulting fetus is frequently composed
entirely of ES cell derivatives [66], whereas the extraembryonic
endoderm almost exclusively originates from the host embryo
[67] (figure 4). Once initiated, the inverse correlation of FGF4
in presumptive epiblast cells and its cognate receptor, FGFR2,
in PrE precursors increases in order to reinforce the differential
identityof the two lineages [20]. By the time the embryo is ready
to implant in the uterus, the cells are irreversibly committed to
their respective lineages [49,68].
The important question of how the symmetry of transcrip-
tional regulators is broken in the early ICM is still debated. It
has been suggested that stochastic fluctuations in gene
expression, followed by signal re-enforcement, are sufficient to
explain the second lineage decision [56]. Alternatively, it has
been proposed that the origin of ICM cells influences their sub-
sequent allocation to epiblast or PrE [28,69]. Live image tracing
of embryos from early cleavage stages revealed a trend for the
majority of cells becoming internalized during the fourth cell
cycle to contribute to the epiblast, whereas those entering the
ICM during the fifth or sixth cell cycle tended to generate PrE
[28]. In another study, which used retrospective lineage tracing
of fluorescent markers, no significant difference was observed
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Figure 4. ES cells taking over the host embryo. Fluorescently labelled (td-
Tomato) mouse ES cells, grown under serum- and feeder-free 2i/LIF culture
conditions (upper panel), were injected into non-labelled host morulae. The
embryonic compartment (postimplantation epiblast) of the resulting chimaeras
apparently consists entirely of donor-derived cells (lower panel). Left images:
bright field; right images: fluorescence. (Online version in colour.)
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5between early and late entering cells [63]. The apparent contro-
versy was resolved, as most discrepancies in the outcome were
interpreted to originate from different experimental set-ups
with both authors agreeing that ‘embryogenesis is a highly
dynamic and regulative process with subtle trends that influ-
ence cell fate’ [70,71]. We support the notion that certain
biases are most likely present in normal embryos, however
any of these reported molecular lineage biases in mouse pre-
implantation development can readily be overridden by
topological rearrangements for the first, and modulation of
FGF signalling for the second lineage decision [49,62,63].8. Naive pluripotency is acquired during
epiblast specification and captured in
embryonic stem cells
Naive pluripotency is the ability of a cell to self-renew while
retaining the potential for unbiased differentiation and germline
contribution in the context of normal development. Compelling
evidence that ES cells are derived from the preimplantation
epiblast was provided by Brook & Gardner [72], by means of
micro-dissection of periimplantation embryos. Almost half
of the epiblasts disaggregated and scattered over the culture
well gave rise to one, two or occasionally three clonal ES cell
lines. The fact that only a maximum of three clonal lines could
be derived from a single preimplantation epiblast led to the
speculation that maybe only a subpopulation of cells can giverise to an ES cell colony [72,73], suggesting that the property of
naive pluripotency is not epiblast-wide. More recently, the use
of two inhibitors (2i) in combination with leukaemia inhibitory
factor (LIF) has allowed the derivation of ES cells from ‘recalci-
trant’ mouse strains and rats [74–76]. PD0325901 mediates
mitogen-activated protein kinase signalling inhibition, thereby
eliminatingauto-induceddifferentiation [77,78],while theglyco-
gen synthase kinase 3 inhibitor CHIR99021 positively stimulates
the biosynthetic capacity of ES cells and stabilizesb-catenin [79].
b-catenin has been shown to sequester a repressor of pluripo-
tency genes, Tcf3 (Tcf7l1), from the nucleus, which stimulates
expression of the naive pluripotency factors Esrrb, Nanog and
Klf2 [80,81]. In 2i/LIF, ES cell derivation from the E4.5 blastocyst
is very efficient. Dissociated ICMs at this stage have been shown
to produce ES cell colonies from all embryos analysed with
numbers of clones ranging from two to 12 [62], throwing into
question the hypothesis that naive pluripotency is restricted to
privileged cells within the epiblast [73].
AlthoughES cells are commonlyderived from the blastocyst
stage, they can be established from various preimplantation
stages and even from single blastomeres [82–85]. The resultant
ES cells have very similar characteristics, suggesting that, during
derivation, they progress to a common developmental stage
from which in vitro self-renewal can ensue. Single cell ES cell
derivation from dissociated embryos from 8-cell to the early
postimplantation eggcylinder stage in2i/LIFongelatindemon-
strates that clonal ES cell lines can be derived efficiently only
from mid- and late blastocyst stages [86]. This study further
showed that during derivation, epiblast cells do not traverse
through distinct developmental states at a transcriptional level
and cluster with the preimplantation epiblast at all times [86].
Thus, the window of opportunity to capture the epiblast state
in vitro coincides with the initiation of ICM heterogeneity and
epiblast specification. This is further supported by the obser-
vation that clonal ES cell colony numbers strictly correlate
with preimplantation epiblast cell numbers, which can be
modulated by activation and inhibition of FGF signalling
[62,86]. Collectively, this demonstrates that naive pluripotency
is a state acquired during preimplantation development,
rather than representing a refined derivative of totipotency.
Epiblast cells can self-renew in vitro and the foundation for
this property may be rooted in their self-renewal ability in vivo.
Diapause is a facultative condition of embryonic arrest in
rodents and other species [87–89], which occurs when implan-
tation is prevented by oestrogen deprivation caused by
persistent suckling of a previous litter. This phenomenon can
be mimicked experimentally by ovariectomy or administration
of an oestrogen antagonist. In diapause, the embryo develops
until the late blastocyst stage and segregates epiblast and
PrE. Interestingly, diapause embryos were originally used to
derive mouse ES cells [90] and have been shown to facilitate
ES cell derivation in conventional culture conditions on feeders
and in the presence of serum [72]. Quantification of inner cells
from diapause embryos revealed a small but significant
increase in ICM cell number, implying that the cells continue
to proliferate [91]. The fact that diapause embryos retain their
developmental potential suggests that mouse epiblast cells
can undergo self-renewal in vivo.
The transcriptional network of the initially totipotent
developmental stages changes drastically after almost every
cell division [20,92] and the common features of totipotency
in vivo therefore remain ill defined. Developmentally, the clos-
est totipotent state to naive pluripotency would be the early
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Figure 5. Representation of hypothetical totipotent and naive pluripotent transcriptional circuitries. Early embryonic cells from zygote to the early ICM stage strictly
undergo cleavage and are unable to support self-sufficient proliferation. This may be caused by incomplete transcriptional interactions of totipotent circuitries with
the basic housekeeping machinery. By contrast, cleavage ends at around the time of epiblast specification, thus rendering the preimplantation epiblast capable of
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6ICM,when the embryo is still undergoing cleavage [5].We pro-
pose that the transcriptional networks operating during
totipotent stages in vivo are incompletely connected to the
basic cellular housekeeping machinery, including cell cycle
checkpoints, and are thus incompatible with self-sufficiency
and autonomous proliferation. By contrast, naive pluripotent
epiblast cells have developed the capacity for cell-autonomous
self-renewal in vitro and, during diapause, in vivo (figure 5).
Currently, there are no culture conditions established to cap-
ture pure populations of authentic, self-renewing blastomeres
or early ICM cells. Such totipotent cell lines would have to
co-express both early epiblast and extraembryonic markers,
readily differentiate into extraembryonic lineages in vitro
within 48 h and efficiently contribute to both embryonic and
extraembryonic tissues in chimaera assays. The establishment
of self-renewing totipotent cells in vitro will strongly depend
upon artificial integration of the totipotent transcriptional cir-
cuit to the housekeeping machinery. Moreover, it is likely
that the temporal presence of maternal genes substantially
contributes to a totipotent transcriptional network. Such key
factors would have to be identified and expressed in a
dosage and time-controlled manner in genetically engineered
cells. In contrast to ES cells, self-renewing totipotent cells
would lack a genuine embryonic counterpart and therefore
it might be challenging, although theoretically possible, to
generate such lines in the future.9. Prerequisites for acquisition of epiblast
identity
Early ICM cells co-express epiblast markers, such as Klf2, Sox2
and Nanog, and early PrE markers, including Gata6, Pdgfra
and FGFR2 [20,56,86]. This delicate balance of opposing line-
age specifiers sets the scene for complete lineage segregationwithin 24 h. Notably, this timing differs substantially from
PrE-like differentiation from ES cells in both embryoid body
[93] and monolayer [94] based protocols, in which robust PrE
marker induction typically takes around 5 days or longer
[94–96]. In presumptive epiblast cells, Nanog and Sox2
become upregulated and repress the sequential activation of
the PrE specifiers [64,97,98].
Transcriptional differences during development would
predict certain associated epigenetic motifs. Genome wide
erasure of DNA-methylation is associated with naive pluripo-
tency [99,100]. This resetting of epigenetic signatures is
potentially crucial for unrestricted germ-layer differentiation.
In females, the paternally inherited X-chromosome is silenced
during the first round of cleavage divisions. Reactivation
occurs transiently and exclusively in the embryonic lineage
just before implantation [101]. Moreover, there is a correlation
of the epigenetic status in epiblast cells in the embryo and ES
cells in vitro. Electron spectroscopic imaging of early mouse
development has shown that in morula and epiblast the
chromatin is distributed as an extended meshwork of uncom-
pacted fibres, indistinguishable from that of ES cells. By
contrast, the chromosomes of extraembryonic lineages were
found to be denser and more compacted [102]. This supports
the notion that naive pluripotency is associated with an open
chromatin state.
Another potential factor involved in epiblast specification
may be the duration of occupation of an internal position
and/or the exposure to extracellular matrix within the ICM.
The early ICM expresses a very specific pattern of Lami-
nin511 (Lama5, Lamb1, Lamc1), integrins and fibronectin
[65,86]. Isolated early ICM cells can develop the properties
of functional epiblast in vitro, when cultured on an attach-
ment matrix consisting of Laminin511 and fibronectin in
the presence of 2i/LIF [86]. The history of cell divisions in
the preimplantation embryo may similarly contribute to the
rstb.royalsocietypublishing
7maturation of a self-sufficient, pluripotent founder cell popu-
lation. Acquisition of epiblast or PrE fate is a gradual process
[20,56,103]. The ability of isolated ICM cells to give rise to ES
cell colonies in vitro appears to coincide with the departure of
potential for inter-lineage conversion [86]. An intriguing possi-
bility is that each ICM cell becomes irreversibly committed to
either PrE or epiblast within a single cell cycle, most likely
the seventh (figure 1). This may also coincide with the end of
cleavage and the initiation of embryonic growth..org
Phil.Trans.R.Soc.B
369:2013054110. Exit from naive pluripotency in vivo
A major rearrangement of the epiblast occurs following
implantation. From a loosely adherent ball of cells, a single-
layered cup-shaped epithelium emerges. This process was
long believed to occur as a result of apoptosis in the cells not
in contact with the visceral endoderm in a BMP-dependent
manner [104]. Recently, this hypothesis has been elegantly
refuted and alternatively attributed to self-organizational
behaviour of the epiblast [105]. During implantation, epiblast
cells rearrange to form a rosette, probably due to basal mem-
brane-stimulated integrin signalling. This establishment of
apical–basal polarity is a prerequisite for lumenogenesis and
subsequent gastrulation [105]. The transcriptional signature
specific to the primed state of pluripotency includes downreg-
ulation of naive pluripotency markers such as Rex1, Klf2, Klf4,
Tbx3 and Tfcp2l1 as well as upregulation of Pou3f1, Otx2 and
FGF5 [86,106–108].
One of the key drivers of exit from naive pluripotency is
FGF signalling. Preimplantation epiblast cells, and ES cells,
their in vitro equivalent, autonomously drive progression of
development by FGF4 expression [57,78]. Activation of the
Erk-cascade directs transition to the early postimplantation
epiblast, a tissue responsive to inductive cues for germ-layer
specification and subsequent development. Furthermore,
preimplantation epiblast cells express Nodal and upregulate
Acvr2b upon implantation [86], which may facilitate the
specification process. By contrast, the Wnt/Gsk3b signalling
pathway has been implicated in maintenance of naive pluripo-
tency [79–81,109]. Downregulation ofWnt/Gsk3b signalling is
required for the transition from a naive to a primed state in vitro[79,109]. Interestingly, PrE cells express high levels of the Wnt
inhibitor Dkk1 [86], potentially facilitating the pre- to postim-
plantation epiblast transition. However, recent work
demonstrated that mice lacking the porcupine homologue
Porcn (a protein required for acetylation and function of Wnt
ligands) develop normally until gastrulation [110]. Further
studies will be required to elucidate fully the complex role of
Wnts, Gsk3b and b-catenin in preimplantation development.
Changes in signalling pathway activities between pre-
and early postimplantation development are reflected in
pluripotent stem cell lines derived from postimplantation epi-
blasts (EpiSCs), which exhibit distinct culture requirements
from those of ES cells [106,107]. EpiSCs self-renew in the pres-
ence of FGF and Activin A, whereas ES cells differentiate
upon activation of these pathways. Conversely, 2i-based cul-
ture conditions are detrimental for EpiSCs, suggesting that
the ability to thrive in the absence of FGF signalling is a dis-
tinctive feature of mouse ES cells. In corroboration of this
observation, the capacity for isolated epiblast cells to generate
naive pluripotent cell lines in feeder-free 2i/LIF culture con-
ditions is rapidly lost in the early postimplantation embryo
[86], an event which functionally marks the exit from naive
pluripotency in vivo.11. Concluding remarks
The establishment of a pool of cells poised to respond to
positional and signalling cues to form a highly complex organ-
ism is an elegant achievement of mammalian development.
The first cell fates are specified by means of positional informa-
tion, with an ‘inside’ requirement for the embryonic lineage.
Cleavage continues and the inner cells set aside another extra-
embryonic lineage, subsequently required for patterning of
the embryo. Towards the end of preimplantation development,
the embryonic cells exit cleavage, a fundamental prerequisite
for embryonic growth. At this time, the epiblast acquires the
intriguing state of naive pluripotency, which can then be
captured in vitro as self-renewing ES cells.
Funding statement. We wish to thank the MRC, Wellcome Trust and
University of Cambridge for our funding.References1. Nichols J, Smith A. 2009 Naive and primed
pluripotent states. Cell Stem Cell 4, 487–492.
(doi:10.1016/j.stem.2009.05.015)
2. Schultz RM. 1993 Regulation of zygotic gene
activation in the mouse. BioEssays 15, 531–538.
(doi:10.1002/bies.950150806)
3. Streffer C, van Beuningen D, Molls M, Zamboglou N,
Schulz S. 1980 Kinetics of cell proliferation in the
pre-implanted mouse embryo in vivo and in vitro.
Cell Tissue Kinetics 13, 135–143.
4. Howlett SK, Webb M, Maro B, Johnson MH. 1985
Meiosis II, mitosis I and the linking interphase: a
study of the cytoskeleton in the fertilised mouse
egg. Cytobios 43, 295–305.
5. Aiken CE, Swoboda PP, Skepper JN, Johnson MH.
2004 The direct measurement of embryogenic
volume and nucleo-cytoplasmic ratio during mousepre-implantation development. Reproduction 128,
527–535. (doi:10.1530/rep.1.00281)
6. Tarkowski AK. 1959 Experiments on the
development of isolated blastomers of mouse
eggs. Nature 184, 1286–1287. (doi:10.1038/
1841286a0)
7. Hoppe PC, Whitten WK. 1972 Does X chromosome
inactivation occur during mitosis of first cleavage?
Nature 239, 520. (doi:10.1038/239520a0)
8. Morris SA, Guo Y, Zernicka-Goetz M. 2012
Developmental plasticity is bound by pluripotency
and the FGF and Wnt signaling pathways. Cell Rep.
2, 756–765. (doi:10.1016/j.celrep.2012.08.029)
9. Tarkowski AK, Wroblewska J. 1967 Development
of blastomeres of mouse eggs isolated at the
4- and 8-cell stage. J. Embryol. Exp. Morphol. 18,
155–180.10. Rossant J. 1976 Postimplantation development of
blastomeres isolated from 4- and 8-cell mouse
eggs. J. Embryol. Exp. Morphol. 36, 283–290.
11. Hillman N, Sherman MI, Graham C. 1972 The
effect of spatial arrangement on cell determination
during mouse development. J. Embryol. Exp.
Morphol. 28, 263–278.
12. Torres-Padilla ME, Parfitt DE, Kouzarides T,
Zernicka-Goetz M. 2007 Histone arginine
methylation regulates pluripotency in the early
mouse embryo. Nature 445, 214–218. (doi:10.
1038/nature05458)
13. Piotrowska-Nitsche K, Perea-Gomez A, Haraguchi S,
Zernicka-Goetz M. 2005 Four-cell stage mouse
blastomeres have different developmental
properties. Development 132, 479–490. (doi:10.
1242/dev.01602)
rstb.royalsocietypublishing.org
Phil.Trans.R.Soc.B
369:20130541
814. Plachta N, Bollenbach T, Pease S, Fraser SE, Pantazis
P. 2011 Oct4 kinetics predict cell lineage patterning
in the early mammalian embryo. Nat. Cell Biol. 13,
117–123. (doi:10.1038/ncb2154)
15. Rossant J, Vijh KM. 1980 Ability of outside cells
from preimplantation mouse embryos to form inner
cell mass derivatives. Dev. Biol. 76, 475–482.
(doi:10.1016/0012-1606(80)90395-4)
16. Lawson KA, Dunn NR, Roelen BA, Zeinstra LM,
Davis AM, Wright CV, Korving JPWFM, Hogan BLM.
1999 Bmp4 is required for the generation of
primordial germ cells in the mouse embryo.
Genes Dev. 13, 424–436. (doi:10.1101/gad.
13.4.424)
17. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-
Nebenius D, Chambers I, Smith A. 1998 Formation
of pluripotent stem cells in the mammalian embryo
depends on the POU transcription factor Oct4.
Cell 95, 379–391. (doi:10.1016/S0092-8674(00)
81769-9)
18. Basilico C, Ambrosetti D, Fraidenraich D, Dailey L.
1997 Regulatory mechanisms governing FGF-4 gene
expression during mouse development. J. Cell
Physiol. 173, 227–232. (doi:10.1002/(SICI)1097-
4652(199711)173:2,227::AID-JCP26.3.0.CO;2-B)
19. Boyer LA et al. 2005 Core transcriptional regulatory
circuitry in human embryonic stem cells. Cell 122,
947–956. (doi:10.1016/j.cell.2005.08.020)
20. Guo G, Huss M, Tong GQ, Wang C, Li Sun L, Clarke
ND, Robson P. 2010 Resolution of cell fate decisions
revealed by single-cell gene expression analysis
from zygote to blastocyst. Dev. Cell. 18, 675–685.
(doi:10.1016/j.devcel.2010.02.012)
21. Johnson MH, Maro B, Takeichi M. 1986 The role of
cell adhesion in the synchronization and orientation
of polarization in 8-cell mouse blastomeres.
J. Embryol. Exp. Morphol. 93, 239–255.
22. Pauken CM, Capco DG. 2000 The expression and
stage-specific localization of protein kinase C
isotypes during mouse preimplantation
development. Dev. Biol. 223, 411–421. (doi:10.
1006/dbio.2000.9763)
23. Plusa B et al. 2005 Downregulation of Par3 and
aPKC function directs cells towards the ICM in the
preimplantation mouse embryo. J. Cell Sci. 118,
505–515. (doi:10.1242/jcs.01666)
24. Louvet S, Aghion J, Santa-Maria A, Mangeat P, Maro
B. 1996 Ezrin becomes restricted to outer cells
following asymmetrical division in the
preimplantation mouse embryo. Dev. Biol. 177,
568–579. (doi:10.1006/dbio.1996.0186)
25. Alarcon VB. 2010 Cell polarity regulator PARD6B
is essential for trophectoderm formation in the
preimplantation mouse embryo. Biol. Reprod. 83,
347–358. (doi:10.1095/biolreprod.110.084400)
26. Johnson MH, Ziomek CA. 1981 Induction of polarity
in mouse 8-cell blastomeres: specificity, geometry,
and stability. J. Cell Biol. 91, 303–308. (doi:10.
1083/jcb.91.1.303)
27. Johnson MH, Ziomek CA. 1981 The foundation
of two distinct cell lineages within the mouse
morula. Cell 24, 71–80. (doi:10.1016/0092-
8674(81)90502-X)28. Morris SA, Teo RT, Li H, Robson P, Glover DM,
Zernicka-Goetz M. 2010 Origin and formation of the
first two distinct cell types of the inner cell mass in
the mouse embryo. Proc. Natl Acad. Sci. USA 107,
6364–6369. (doi:10.1073/pnas.0915063107)
29. Chambers I, Colby D, Robertson M, Nichols J, Lee S,
Tweedie S, Smith A. 2003 Functional expression
cloning of Nanog, a pluripotency sustaining factor in
embryonic stem cells. Cell 113, 643–655. (doi:10.
1016/S0092-8674(03)00392-1)
30. Ralston A, Rossant J. 2008 Cdx2 acts downstream of
cell polarization to cell-autonomously promote
trophectoderm fate in the early mouse embryo.
Dev. Biol. 313, 614–629. (doi:10.1016/j.ydbio.
2007.10.054)
31. Niwa H, Toyooka Y, Shimosato D, Strumpf D,
Takahashi K, Yagi R, Rossant J. 2005 Interaction
between Oct3/4 and Cdx2 determines
trophectoderm differentiation. Cell 123, 917–929.
(doi:10.1016/j.cell.2005.08.040)
32. Dietrich JE, Hiiragi T. 2007 Stochastic patterning in
the mouse pre-implantation embryo. Development
134, 4219–4231. (doi:10.1242/dev.003798)
33. Strumpf D et al. 2005 Cdx2 is required for
correct cell fate specification and differentiation
of trophectoderm in the mouse blastocyst.
Development 132, 2093–2102. (doi:10.1242/
dev.01801)
34. Nishioka N, Yamamoto S, Kiyonari H, Sato H,
Sawada A, Ota M, Nakao K, Sasaki H. 2008 Tead4 is
required for specification of trophectoderm in pre-
implantation mouse embryos. Mech. Dev. 125,
270–283. (doi:10.1016/j.mod.2007.11.002)
35. Yagi R, Kohn MJ, Karavanova I, Kaneko KJ, Vullhorst
D, DePamphilis ML, Buonanno A. 2007 Transcription
factor TEAD4 specifies the trophectoderm lineage at
the beginning of mammalian development.
Development 134, 3827–3836. (doi:10.1242/
dev.010223)
36. Nishioka N et al. 2009 The Hippo signaling pathway
components Lats and Yap pattern Tead4 activity to
distinguish mouse trophectoderm from inner cell
mass. Dev. Cell. 16, 398–410. (doi:10.1016/j.devcel.
2009.02.003)
37. Ralston A et al. 2010 Gata3 regulates trophoblast
development downstream of Tead4 and in parallel
to Cdx2. Development 137, 395–403. (doi:10.1242/
dev.038828)
38. Lorthongpanich C, Messerschmidt DM, Chan SW,
Hong W, Knowles BB, Solter D. 2013 Temporal
reduction of LATS kinases in the early
preimplantation embryo prevents ICM lineage
differentiation. Genes Dev. 27, 1441–1446. (doi:10.
1101/gad.219618.113)
39. Hirate Y et al. 2013 Polarity-dependent
distribution of angiomotin localizes Hippo
signaling in preimplantation embryos. Curr.
Biol. 23, 1181–1194. (doi:10.1016/j.cub.
2013.05.014)
40. Cockburn K, Biechele S, Garner J, Rossant J. 2013
The Hippo pathway member Nf2 is required for
inner cell mass specification. Curr. Biol. 23,
1195–1201. (doi:10.1016/j.cub.2013.05.044)41. Lorthongpanich C, Doris TP, Limviphuvadh V,
Knowles BB, Solter D. 2012 Developmental fate and
lineage commitment of singled mouse blastomeres.
Development 139, 3722–3731. (doi:10.1242/dev.
086454)
42. Graham CF, Lehtonen E. 1979 Formation and
consequences of cell patterns in preimplantation
mouse development. J. Embryol. Exp. Morphol. 49,
277–294.
43. Suzuki H, Togashi M, Adachi J, Toyoda Y. 1995
Developmental ability of zona-free mouse embryos
is influenced by cell association at the 4-cell stage.
Biol. Reprod. 53, 78–83. (doi:10.1095/biolreprod53.
1.78)
44. Handyside AH. 1978 Time of commitment of inside
cells isolated from preimplantation mouse embryos.
J. Embryol. Exp. Morphol. 45, 37–53.
45. Spindle AI. 1978 Trophoblast regeneration by inner
cell masses isolated from cultured mouse embryos.
J. Exp. Zool. 203, 483–489. (doi:10.1002/jez.
1402030315)
46. Nichols J, Gardner RL. 1984 Heterogeneous
differentiation of external cells in individual isolated
early mouse inner cell masses in culture. J. Embryol.
Exp. Morphol. 80, 225–240.
47. Hogan B, Tilly R. 1978 In vitro development of inner
cell masses isolated immunosurgically from mouse
blastocysts. I. Inner cell masses from 3.5-day p.c.
blastocysts incubated for 24 h before
immunosurgery. J. Embryol. Exp. Morphol. 45,
93–105.
48. Rossant J, Lis WT. 1979 Potential of isolated mouse
inner cell masses to form trophectoderm derivatives
in vivo. Dev. Biol. 70, 255–261. (doi:10.1016/0012-
1606(79)90022-8)
49. Grabarek JB, Zyzynska K, Saiz N, Piliszek A,
Frankenberg S, Nichols J, Hadjantonakis A-K,
Plusa B. 2012 Differential plasticity of epiblast and
primitive endoderm precursors within the ICM of
the early mouse embryo. Development 139,
129–139. (doi:10.1242/dev.067702)
50. Xenopoulos P, Kang M, Hadjantonakis AK. 2012 Cell
lineage allocation within the inner cell mass of the
mouse blastocyst. Results Probl. Cell Differ. 55,
185–202. (doi:10.1007/978-3-642-30406-4_10)
51. Schrode N, Xenopoulos P, Piliszek A, Frankenberg S,
Plusa B, Hadjantonakis AK. 2013 Anatomy of a
blastocyst: cell behaviors driving cell fate choice and
morphogenesis in the early mouse embryo. Genesis
51, 219–233. (doi:10.1002/dvg.22368)
52. Yamanaka Y, Ralston A, Stephenson RO, Rossant J.
2006 Cell and molecular regulation of the mouse
blastocyst. Dev. Dyn. 235, 2301–2314. (doi:10.
1002/dvdy.20844)
53. Oron E, Ivanova N. 2012 Cell fate regulation in early
mammalian development. Phys. Biol. 9, 045002.
(doi:10.1088/1478-3975/9/4/045002)
54. Saiz N, Plusa B. 2013 Early cell fate decisions in the
mouse embryo. Reproduction 145, R65–R80.
(doi:10.1530/REP-12-0381)
55. Plusa B, Piliszek A, Frankenberg S, Artus J,
Hadjantonakis AK. 2008 Distinct sequential cell
behaviours direct primitive endoderm formation in
rstb.royalsocietypublishing.org
Phil.Trans.R.Soc.B
369:20130541
9the mouse blastocyst. Development 135,
3081–3091. (doi:10.1242/dev.021519)
56. Ohnishi Y et al. 2014 Cell-to-cell expression
variability followed by signal reinforcement
progressively segregates early mouse lineages. Nat.
Cell Biol. 16, 27–37. (doi:10.1038/ncb2881)
57. Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai
P. 1998 Targeted disruption of fibroblast growth
factor (FGF) receptor 2 suggests a role for FGF
signaling in pregastrulation mammalian
development. Proc. Natl Acad. Sci. USA 95,
5082–5087. (doi:10.1073/pnas.95.9.5082)
58. Rappolee DA, Basilico C, Patel Y, Werb Z. 1994
Expression and function of FGF-4 in peri-
implantation development in mouse embryos.
Development 120, 2259–2269.
59. Feldman B, Poueymirou W, Papaioannou VE,
DeChiara TM, Goldfarb M. 1995 Requirement of
FGF-4 for postimplantation mouse development.
Science 267, 246–249. (doi:10.1126/science.
7809630)
60. Cheng AM et al. 1998 Mammalian Grb2 regulates
multiple steps in embryonic development and
malignant transformation. Cell 95, 793–803.
(doi:10.1016/S0092-8674(00)81702-X)
61. Kang M, Piliszek A, Artus J, Hadjantonakis AK. 2013
FGF4 is required for lineage restriction and salt-and-
pepper distribution of primitive endoderm factors
but not their initial expression in the mouse.
Development 140, 267–279. (doi:10.1242/dev.
084996)
62. Nichols J, Silva J, Roode M, Smith A. 2009
Suppression of Erk signalling promotes ground state
pluripotency in the mouse embryo. Development
136, 3215–3222. (doi:10.1242/dev.038893)
63. Yamanaka Y, Lanner F, Rossant J. 2010 FGF signal-
dependent segregation of primitive endoderm and
epiblast in the mouse blastocyst. Development 137,
715–724. (doi:10.1242/dev.043471)
64. Frankenberg S, Gerbe F, Bessonnard S, Belville C,
Pouchin P, Bardot O, Chazaud C. 2011 Primitive
endoderm differentiates via a three-step mechanism
involving Nanog and RTK signaling. Dev. Cell. 21,
1005–1013. (doi:10.1016/j.devcel.2011.10.019)
65. Tang F, Barbacioru C, Bao S, Lee C, Nordman E,
Wang X, Lao K, Surani MA. 2010 Tracing the
derivation of embryonic stem cells from the inner
cell mass by single-cell RNA-Seq analysis. Cell Stem
Cell 6, 468–478. (doi:10.1016/j.stem.2010.03.015)
66. Poueymirou WT et al. 2007 F0 generation mice fully
derived from gene-targeted embryonic stem cells
allowing immediate phenotypic analyses. Nat.
Biotechnol. 25, 91–99. (doi:10.1038/nbt1263)
67. Beddington RS, Robertson EJ. 1989 An assessment
of the developmental potential of embryonic stem
cells in the midgestation mouse embryo.
Development 105, 733–737.
68. Gardner RL, Rossant J. 1979 Investigation of the fate
of 4–5 day post-coitum mouse inner cell mass cells
by blastocyst injection. J. Embryol. Exp. Morphol. 52,
141–152.
69. Krupa M, Mazur E, Szczepanska K, Filimonow K,
Maleszewski M, Suwinska A. 2014 Allocation ofinner cells to epiblast versus primitive endoderm in
the mouse embryo is biased but not determined by
the round of asymmetric divisions (8–.16- and
16–.32-cells). Dev. Biol. 385, 136–148. (doi:10.
1016/j.ydbio.2013.09.008)
70. Yamanaka Y. 2011 Response: Cell fate in the early
mouse embryo–sorting out the influence of
developmental history on lineage choice. Reprod.
Biomed. Online 22, 525–527; discussion 8. (doi:10.
1016/j.rbmo.2011.03.011)
71. Morris SA. 2011 Cell fate in the early mouse
embryo: sorting out the influence of developmental
history on lineage choice. Reprod. Biomed.
Online 22, 521–524. (doi:10.1016/j.rbmo.2011.
02.009)
72. Brook FA, Gardner RL. 1997 The origin and efficient
derivation of embryonic stem cells in the mouse.
Proc. Natl Acad. Sci. USA 94, 5709–5712. (doi:10.
1073/pnas.94.11.5709)
73. Chu LF, Surani MA, Jaenisch R, Zwaka TP. 2011
Blimp1 expression predicts embryonic stem cell
development in vitro. Curr. Biol. 21, 1759–1765.
(doi:10.1016/j.cub.2011.09.010)
74. Buehr M et al. 2008 Capture of authentic embryonic
stem cells from rat blastocysts. Cell 135,
1287–1298. (doi:10.1016/j.cell.2008.12.007)
75. Hanna J et al. 2010 Human embryonic stem cells
with biological and epigenetic characteristics similar
to those of mouse ESCs. Proc. Natl Acad. Sci. USA
107, 9222–9227. (doi:10.1073/pnas.1004584107)
76. Nichols J, Jones K, Phillips JM, Newland SA, Roode
M, Mansfield W, Smith A, Cooke A. 2009 Validated
germline-competent embryonic stem cell lines from
nonobese diabetic mice. Nat. Med. 15, 814–818.
(doi:10.1038/nm.1996)
77. Burdon T, Stracey C, Chambers I, Nichols J, Smith A.
1999 Suppression of SHP-2 and ERK signalling
promotes self-renewal of mouse embryonic stem
cells. Dev. Biol. 210, 30–43. (doi:10.1006/dbio.
1999.9265)
78. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray
J, Meloche S, Smith A. 2007 FGF stimulation of the
Erk1/2 signalling cascade triggers transition of
pluripotent embryonic stem cells from self-renewal
to lineage commitment. Development 134,
2895–2902. (doi:10.1242/dev.02880)
79. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B,
Woodgett J, Cohen P, Smith A. 2008 The ground
state of embryonic stem cell self-renewal. Nature
453, 519–523. (doi:10.1038/nature06968)
80. Martello G, Sugimoto T, Diamanti E, Joshi A,
Hannah R, Ohtsuka S, Niwa H, Smith A. 2012 Esrrb
is a pivotal target of the Gsk3/Tcf3 axis regulating
embryonic stem cell self-renewal. Cell Stem Cell 11,
491–504. (doi:10.1016/j.stem.2012.06.008)
81. Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook
A, Kemler R, Smith A. 2011 Inhibition of glycogen
synthase kinase-3 alleviates Tcf3 repression of the
pluripotency network and increases embryonic stem
cell resistance to differentiation. Nat. Cell Biol. 13,
838–845. (doi:10.1038/ncb2267)
82. Delhaise F, Bralion V, Schuurbiers N, Dessy F. 1996
Establishment of an embryonic stem cell line from8-cell stage mouse embryos. Eur. J. Morphol. 34,
237–243. (doi:10.1076/ejom.34.4.0237)
83. Tesar PJ. 2005 Derivation of germ-line-competent
embryonic stem cell lines from preblastocyst
mouse embryos. Proc. Natl Acad. Sci. USA 102,
8239–8244. (doi:10.1073/pnas.0503231102)
84. Chung Y, Klimanskaya I, Becker S, Marh J, Lu SJ,
Johnson J, Meisner L, Lanza R. 2006 Embryonic and
extraembryonic stem cell lines derived from single
mouse blastomeres. Nature 439, 216–219. (doi:10.
1038/nature04277)
85. Wakayama S, Hikichi T, Suetsugu R, Sakaide Y, Bui
HT, Mizutani E, Wakayama T. 2007 Efficient
establishment of mouse embryonic stem cell
lines from single blastomeres and polar bodies.
Stem Cells 25, 986–993. (doi:10.1634/stemcells.
2006-0615)
86. Boroviak TLR, Bertone P, Smith A, Nichols J.
In press. The ability of inner cell mass cells to self-
renew as embryonic stem cells is acquired upon
epiblast specification. Nat. Cell Biol.
87. Hondo E, Stewart CL. 2005 Profiling gene
expression in growth-arrested mouse embryos in
diapause. Genome Biol. 6, 202. (doi:10.1186/gb-
2004-6-1-202)
88. Ketchel MM, Banik UK, Mantalenakis SJ. 1966 A
study of delayed implantation caused by parabiosis
in pregnant rats. J. Reprod. Fertil. 11, 213–219.
(doi:10.1530/jrf.0.0110213)
89. Mantalenakis SJ, Ketchel MM. 1966 Frequency and
extent of delayed implantation in lactating rats and
mice. J. Reprod. Fertil. 12, 391–394. (doi:10.1530/
jrf.0.0120391)
90. Evans MJ, Kaufman MH. 1981 Establishment in
culture of pluripotential cells from mouse embryos.
Nature 292, 154–156. (doi:10.1038/292154a0)
91. Nichols J, Chambers I, Taga T, Smith A. 2001
Physiological rationale for responsiveness of mouse
embryonic stem cells to gp130 cytokines.
Development 128, 2333–2339.
92. Xue Z et al. 2013 Genetic programs in human and
mouse early embryos revealed by single-cell RNA
sequencing. Nature 500, 593–597. (doi:10.1038/
nature12364)
93. Martin GR. 1981 Isolation of a pluripotent cell line
from early mouse embryos cultured in medium
conditioned by teratocarcinoma stem cells. Proc.
Natl Acad. Sci. USA 78, 7634–7638. (doi:10.1073/
pnas.78.12.7634)
94. Cho LT, Wamaitha SE, Tsai IJ, Artus J, Sherwood RI,
Pedersen RA, Hadjantonakis A-K, Niakan KK. 2012
Conversion from mouse embryonic to extra-
embryonic endoderm stem cells reveals distinct
differentiation capacities of pluripotent stem cell
states. Development 139, 2866–2877. (doi:10.
1242/dev.078519)
95. Doughton G, Wei J, Tapon N, Welham MJ, Chalmers
AD. 2014 Formation of a polarised primitive
endoderm layer in embryoid bodies requires fgfr/erk
signalling. PLoS ONE 9, e95434. (doi:10.1371/
journal.pone.0095434)
96. Wang Y, Smedberg JL, Cai KQ, Capo-Chichi DC, Xu
XX. 2011 Ectopic expression of GATA6 bypasses
rstb.royalsocietypublishing.org
Phil.Trans.R.Soc.B
369:20130541
10requirement for Grb2 in primitive endoderm
formation. Dev. Dyn. 240, 566–576. (doi:10.1002/
dvdy.22447)
97. Artus J, Piliszek A, Hadjantonakis AK. 2011 The
primitive endoderm lineage of the mouse
blastocyst: sequential transcription factor activation
and regulation of differentiation by Sox17. Dev.
Biol. 350, 393–404. (doi:10.1016/j.ydbio.2010.
12.007)
98. Chazaud C, Yamanaka Y, Pawson T, Rossant J. 2006
Early lineage segregation between epiblast and
primitive endoderm in mouse blastocysts through
the Grb2-MAPK pathway. Dev. Cell. 10, 615–624.
(doi:10.1016/j.devcel.2006.02.020)
99. Leitch HG et al. 2013 Naive pluripotency is
associated with global DNA hypomethylation. Nat.
Struct. Mol. Biol. 20, 311–316. (doi:10.1038/
nsmb.2510)
100. Ficz G et al. 2013 FGF signaling inhibition in ESCs
drives rapid genome-wide demethylation to the
epigenetic ground state of pluripotency. Cell Stem
Cell 13, 351–359. (doi:10.1016/j.stem.2013.06.004)101. Heard E. 2004 Recent advances in X-chromosome
inactivation. Curr. Opin. Cell Biol. 16, 247–255.
(doi:10.1016/j.ceb.2004.03.005)
102. Rugg-Gunn PJ, Cox BJ, Ralston A, Rossant J. 2010
Distinct histone modifications in stem cell lines and
tissue lineages from the early mouse embryo. Proc.
Natl Acad. Sci. USA 107, 10 783–10 790. (doi:10.
1073/pnas.0914507107)
103. Kurimoto K et al. 2006 An improved single-cell
cDNA amplification method for efficient high-
density oligonucleotide microarray analysis. Nucleic
Acids Res. 34, e42. (doi:10.1093/nar/gkl050)
104. Coucouvanis E, Martin GR. 1999 BMP signaling plays
a role in visceral endoderm differentiation and
cavitation in the early mouse embryo. Development
126, 535–546.
105. Bedzhov I, Zernicka-Goetz M. 2014 Self-organizing
properties of mouse pluripotent cells initiate
morphogenesis upon implantation. Cell 156,
1032–1044. (doi:10.1016/j.cell.2014.01.023)
106. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ,
Evans EP, Mack DL, Gardner RL, McKay RDG.2007 New cell lines from mouse epiblast share
defining features with human embryonic stem
cells. Nature 448, 196–199. (doi:10.1038/
nature05972)
107. Brons IG et al. 2007 Derivation of pluripotent
epiblast stem cells from mammalian embryos.
Nature 448, 191–195. (doi:10.1038/nature05950)
108. Iwafuchi-Doi M, Matsuda K, Murakami K, Niwa H,
Tesar PJ, Aruga J, Matsuo I, Kondoh H. 2012
Transcriptional regulatory networks in epiblast cells
and during anterior neural plate development as
modeled in epiblast stem cells. Development 139,
3926–3937. (doi:10.1242/dev.085936)
109. ten Berge D, Kurek D, Blauwkamp T, Koole W,
Maas A, Eroglu E, Siu RK, Nusse R. 2011 Embryonic
stem cells require Wnt proteins to prevent
differentiation to epiblast stem cells. Nat. Cell
Biol. 13, 1070–1075. (doi:10.1038/ncb2314)
110. Biechele S, Cockburn K, Lanner F, Cox BJ, Rossant J.
2013 Porcn-dependent Wnt signaling is not
required prior to mouse gastrulation. Development
140, 2961–2971. (doi:10.1242/dev.094458)
